Related Experiment Videos

Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population

L Fanning1, E Kenny, M Sheehan

  • 1Department of Medicine, National University of Ireland, Cork, University College Cork, Ireland. L.FANNING@UCCE.IE

Insights

Quantitative viral load monitoring in hepatitis C virus (HCV) infection showed a weak correlation with liver inflammation but not fibrosis or ALT levels in a homogenous patient group.

Area of Science:

  • Hepatology
  • Virology
  • Clinical Biochemistry

Background:

  • Hepatitis C virus (HCV) progression monitoring traditionally relies on clinical, biochemical, and histological markers.
  • Quantitative viral load measurement via reverse-transcription polymerase chain reaction (RT-PCR) is proposed as a more reliable disease marker.
  • Previous studies reported conflicting viral titer data due to patient heterogeneity.

Purpose of the Study:

  • To correlate quantitative serum viral load with alanine transaminase (ALT) levels and histological findings.
  • To investigate these correlations within a homogenous population to minimize confounding factors.

Main Methods:

  • Study involved 77 Rhesus-negative women with chronic hepatitis C type 1b, uniformly infected and untreated.
  • Liver biopsies were assessed by a single, blinded histopathologist for inflammation and fibrosis.
  • Serum viral load and ALT levels were quantified and correlated with histological data.

Main Results:

  • A weak but significant correlation was observed between serum viral load and the degree of liver inflammation (rs =.26; P <.05).
  • No significant correlation was found between serum viral load and the degree of liver fibrosis (P =.06).
  • Serum viral load did not correlate significantly with ALT levels, though ALT correlated with inflammation (rs =.241; P =.035).

Conclusions:

  • Quantitative serum viral load has a limited correlation with liver inflammation and no significant correlation with fibrosis or ALT in this specific HCV patient cohort.
  • These findings highlight the complexity of HCV disease progression markers and the importance of homogenous study populations.

Related Concept Videos